1. Chen S, Ren C, Zheng H, Sun X, Dai J. The effect of long non-coding RNA (lncRNA) HCP5 on regulating epithelial-mesenchymal transition (EMT)-related markers in gastric carcinoma is partially reversed by miR-27b-3p. Med Sci Monit 2020; 26: e921383.
2.
Chen Y, Chen G, Zhang B, Liu C, Yu Y, Jin Y. miR-27b-3p suppresses cell proliferation, migration and invasion by targeting LIMK1 in colorectal cancer. Int J Clin Exp Pathol 2017; 10: 9251-9261.
3.
Cui X, Zhang H, Chen T, Yu W, Shen K. Long noncoding RNA SNHG22 induces cell migration, invasion, and angiogenesis of gastric cancer cells via microRNA-361-3p/HMGA1/Wnt/β-catenin axis. Cancer Manag Res 2020; 12: 12867-12883.
4.
Fang X, Zhang J, Li C, Liu J, Shi Z, Zhou P. Long non-coding RNA SNHG22 facilitates the malignant phenotypes in triple-negative breast cancer via sponging miR-324-3p and upregulating SUDS3. Cancer Cell Int 2020; 20: 252.
5.
Fu C, Li D, Zhang X, Liu N, Chi G, Jin X. LncRNA PVT1 facilitates tumorigenesis and progression of glioma via regulation of MiR-128-3p/GREM1 axis and BMP signaling pathway. Neurotherapeutics 2018; 15: 1139-1157.
6.
Gao W, Wang X, Zhou Y, Wang X, Yu Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther 2022; 7: 196.
7.
Guan N, Zheng H, Wu X, Xie L, Tong X. SP1-regulated non-coding RNA SNHG22 promotes ovarian cancer growth and glycolysis. Cancer Manag Res 2021; 13: 7299-7309.
8.
Han M, Li N, Li F, Wang H, Ma L. MiR-27b-3p exerts tumor suppressor effects in esophageal squamous cell carcinoma by targeting Nrf2. Hum Cell 2020; 33: 641-651.
9.
Han PP, Zhang GQ, Li L, Yue L. Downregulation of USP33 inhibits Slit/Robo signaling pathway and is associated with poor patient survival of glioma. J Neurosurg Sci 2020; 67: 113-120.
10.
Huang QR, Li JW, Yan P, Jiang Q, Guo FZ, Zhao YN, Mo LG. Establishment and validation of a ferroptosis-related lncRNA signature for prognosis prediction in lower-grade glioma. Front Neurol 2022; 13: 861438.
11.
Isaev K, Jiang L, Wu S, Lee CA, Watters V, Fort V, Tsai R, Cou-
12.
tinho FJ, Hussein SMI, Zhang J, Wu J, Dirks PB, Schramek D, Reimand J. Pan-cancer analysis of non-coding transcripts reveals the prognostic onco-lncRNA HOXA10-AS in gliomas. Cell Rep 2021; 37: 109873.
13.
Kim SM, Lim EJ, Yoo KC, Zhao Y, Kang JH, Lim EJ, Shin I, Kang SG, Lim HW, Lee SJ. Glioblastoma-educated mesenchymal stem-like cells promote glioblastoma infiltration via extracellular matrix remodelling in the tumour microenvironment. Clin Transl Med 2022; 12: e997.
14.
Li L, Guo X, Liu J, Chen B, Gao Z, Wang Q. The role of miR-27b-3p/HOXA10 axis in the pathogenesis of endometriosis. Ann Palliat Med 2021; 10: 3162-3170.
15.
Li X, Wang H. Long non-coding RNA GABPB1-AS1 augments malignancy of glioma cells by sequestering microRNA-330 and reinforcing the ZNF367/cell cycle signaling pathway. Neuropsychiatr Dis Treat 2021; 17: 2073-2087.
16.
Li Y, Wang X, Zhao Z, Shang J, Li G, Zhang R. LncRNA NEAT1 promotes glioma cancer progression via regulation of miR-98-5p/BZW1. Biosci Rep 2021; 41: BSR20200767.
17.
Li Z, Xue H, Tan G, Xu Z. Effects of miRNAs, lncRNAs and circRNAs on osteoporosis as regulatory factors of bone homeostasis (Review). Mol Med Rep 2021; 24: 788.
18.
Liu ZZ, Tian YF, Wu H, Ouyang SY, Kuang WL. LncRNA H19 promotes glioma angiogenesis through miR-138/HIF-1α/VEGF axis. Neoplasma 2020; 67: 111-118.
19.
Mao X, Ji T, Liu A, Weng Y. ELK4-mediated lncRNA SNHG22 promotes gastric cancer progression through interacting with EZH2 and regulating miR-200c-3p/Notch1 axis. Cell Death Dis 2021; 12: 957.
20.
Miao W, Li N, Gu B, Yi G, Su Z, Cheng H. MiR-27b-3p suppresses glioma development via targeting YAP1. Biochem Cell Biol 2020; 98: 466-473.
21.
Nan Y, Guo L, Zhen Y, Wang L, Ren B, Chen X, Lu Y, Yu K, Zhong Y, Huang Q. miRNA-451 regulates the NF-κB signaling pathway by targeting IKKβ to inhibit glioma cell growth. Cell Cycle (Georgetown, Tex) 2021; 20: 1967-1977.
22.
Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S. Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet 2004; 36: 40-45.
23.
Qu L, Lin P, Lin M, Ye S, Papa Akuetteh PD, Youyou Z. Fraxetin inhibits the proliferation and metastasis of glioma cells by inactivating JAK2/STAT3 signaling. Evid Based Complement Alternat Med 2021; 2021: 5540139.
24.
Su Y, Liang C, Yang Q. LncRNA MALAT1 promotes glioma cell growth through sponge miR-613. J BUON 2021; 26: 984-991.
25.
Sun W, Li J, Zhou L, Han J, Liu R, Zhang H, Ning T, Gao Z, Liu B, Chen X, Ba Y. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer. Theranostics 2020; 10: 1981-1996.
26.
Tamai S, Ichinose T, Tsutsui T, Tanaka S, Garaeva F, Sabit H, Nakada M. Tumor microenvironment in glioma invasion. Brain Sci 2022; 12: 505.
27.
Wang WJ, Sun K, Li FY, Hui XB, Liu D, Liu J, Wang XD. LncRNA HANR aggravates the malignant progression of glioma via targeting miRNA-335. Eur Rev Med Pharmacol Sci 2020; 24: 758-765.
28.
Xiong Y, Pang M, Du Y, Yu X, Yuan J, Liu W, Wang L, Liu X. The LINC01929/miR-6875-5p/ADAMTS12 axis in the ceRNA network regulates the development of advanced bladder cancer. Front Oncol 2022; 12: 856560.
29.
Xue L, Wang Y, Yue S, Zhang J. The expression of miRNA-221 and miRNA-222 in gliomas patients and their prognosis. Neurol Sci 2017; 38: 67-73.
30.
Yao J, Wang C, Dong X, Zhang Y, Li Y, Zhou H, Zhang L. lncRNA SNHG22 sponges miR 128 3p to promote the progression of colorectal cancer by upregulating E2F3. Int J Oncol 2021; 59: 71.
31.
Zeng WJ, Cheng Q, Wen ZP, Wang JY, Chen YH, Zhao J, Gong ZC, Chen XP. Aberrant ASPM expression mediated by transcriptional regulation of FoxM1 promotes the progression of gliomas. J Cell Mol Med 2020; 24: 9613-9626.
32.
Zhan WL, Gao N, Tu GL, Tang H, Gao L, Xia Y. LncRNA LINC00689 promotes the tumorigenesis of glioma via mediation of miR-526b-3p/IGF2BP1 axis. Neuromolecular Med 2021; 23: 383-394.
33.
Zhang PF, Wu J, Luo JH, Li KS, Wang F, Huang W, Wu Y, Gao SP, Zhang XM, Zhang PN. SNHG22 overexpression indicates poor prognosis and induces chemotherapy resistance via the miR-2467/Gal-1 signaling pathway in epithelial ovarian carcinoma. Aging 2019; 11: 8204-8216.
34.
Zhang Y, Lu C, Cui H. Long non-coding RNA SNHG22 facilitates hepatocellular carcinoma tumorigenesis and angiogenesis via DNA methylation of microRNA miR-16-5p. Bioengineered 2021; 12: 7446-7458.
35.
Zhang ZQ, Wang X, Xue BH, Zhao Y, Xie F, Wang SD, Xue C, Wang Y, Zhang YS, Qian LJ. Chronic stress promotes glioma cell proliferation via the PI3K/Akt signaling pathway. Oncol Rep 2021; 46: 202.
